<qa>  What is the name of the vaccine that is eligible for administration?- Patients are eligible for administration of their vaccine if they present with B-CLL not in Richters transformation with group A or without group B measurable disease. Untreated or complete remission patients will be enrolled for vaccine administration in a therapeutic i.e. no chemotherapy window of three months. If during these three months necessary to complete the vaccine study the patient presents with rapid clinical progression, he or she will be excluded from our current study and will receive treatment according to the standard institutional guidelines. IMPORTANT NOTE: Vaccine production for complete remission patients can only be achieved if tumor cells have been collected BEFORE entering complete remission. 